Cargando…
Posterior reversible encephalopathy syndrome and takotsubo cardiomyopathy associated with lenvatinib therapy for thyroid cancer: a case report and review
As immunotherapies including tyrosine kinase inhibitors become more widely used for the treatment of a variety of malignancies, it is important for prescribers and patients to understand the potential adverse effects associated with these drugs. It is especially important to understand the potential...
Autores principales: | Chae, Young Kwang, Chiec, Lauren, Adney, Scott K., Waitzman, Josh, Costa, Ricardo, Carneiro, Benedito, Matsangou, Maria, Agulnik, Mark, Kopp, Peter, Giles, Frank |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6021337/ https://www.ncbi.nlm.nih.gov/pubmed/29963277 http://dx.doi.org/10.18632/oncotarget.25606 |
Ejemplares similares
-
Spotlight on lenvatinib in the treatment of thyroid cancer: patient selection and perspectives
por: Costa, Ricardo, et al.
Publicado: (2016) -
A Case of Posterior Reversible Encephalopathy Due to Takotsubo Cardiomyopathy Triggered by Aerophobia
por: Çetin, Güldeniz, et al.
Publicado: (2023) -
Posterior Reversible Encephalopathy Syndrome after Lenvatinib Therapy in a Patient with Anaplastic Thyroid Carcinoma
por: Osawa, Yoko, et al.
Publicado: (2017) -
Posterior Reversible Encephalopathy Syndrome after Lenvatinib Therapy in a Patient with Olfactory Neuroblastoma
por: Tseng, Yu-Ju, et al.
Publicado: (2022) -
Posterior Reversible Encephalopathy Syndrome (PRES) and Takotsubo: A Heart and Brain Affair!
por: Perwez, Talha, et al.
Publicado: (2021)